Tuesday, Sept. 9
7:00 a.m.- 8:15 a.m.
The Role of Pharmacogenomics with Anti-Infective Agents
Top 10 Beta-Lactamase Papers from 2014
Challenges in the Regulation of Broad Multiplex Diagnostic Devices in Microbiology
Planting the Seeds of Early Antibacterial Drug Discovery
Update on Vaccines for HIV-Infected Patients
Latest Issues in Clostridium difficile Prevention and Control
Challenging Problems in STI Management
Fungal Connoisseurs Rejoice: Mycology Beyond Randomized Trials
Artemisinin-Resistant Plasmodium falciparum Malaria: Latest Findings from In Vitro, Genomic, Epidemiological, and Clinical Studies
Respiratory Viruses in Stem Cell Transplantation: Update on Prevention, Diagnosis, and Treatment
8:30 a.m. - 10:30 a.m.
The Challenges with Old and New Drugs for the Treatment of Tuberculosis
The Treatment and Control of Malaria
MDR Organisms in Specific Patient Populations: Epidemiology and Clinical Implications
Epidemiology, Diagnosis, and Resistance Testing of Sexually Transmitted Infections
Update on Infectious Diseases in Adopted and Refugee Children
On the Road to Cure
Controversies in Infection Prevention
Challenging Infections in Older Adults
Can We Predict Fungal Infections?
New Developments in Influenza Viruses
8:30 a.m. - 11:00 a.m.
Gram-Positive Organisms: From Pathogenesis to Genetic Susceptibility
Mechanisms of Vancomycin and Daptomycin Resistance
Recent Advances in the Fight against Mycobacterium sp.
Epidemiology of Clostridium difficile Infection
Viral and Fungal Infections: Ongoing Challenges for Transplant Recipients